Ricky Hopson - Aug 1, 2023 Form 4 Insider Report for Catalent, Inc. (CTLT)

Role
Pres. Clinical Dev Supply Div
Signature
/s/ Amy Fallone, attorney-in-fact
Stock symbol
CTLT
Transactions as of
Aug 1, 2023
Transactions value $
-$9,333
Form type
4
Date filed
8/3/2023, 04:47 PM
Previous filing
Jan 25, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTLT Common Stock Sale -$9.33K -195 -1.19% $47.86 16.3K Aug 1, 2023 Direct F1, F2, F3
transaction CTLT Common Stock Award $0 +4.79K +29.46% $0.00 21K Aug 1, 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTLT Options to purchase Common Stock Award $0 +10.7K $0.00 10.7K Aug 1, 2023 Common Stock 10.7K $46.51 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the reporting person through an automatic "sell-to-cover" transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
F2 Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $47.72 to $48.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes restricted stock units.
F4 Restricted stock units received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur in three equal annual installments beginning on August 1, 2024.
F5 Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
F6 The options vest and become exercisable in four equal annual installments beginning on August 1, 2024.